Want to join the conversation?
$PVH 2Q15 Call: 3Q15 EPS on a non-GAAP basis is currently projected to be in a range of $2.45-2.50, which reflects an expected $0.40 per share negative impact primarily related to foreign currency exchange rates as described above. Excluding this negative impact, EPS on a non-GAAP basis is expected to increase 11-13% vs. 3Q14 non-GAAP EPS of $2.56.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?